201 related articles for article (PubMed ID: 28097503)
21. Characteristics and clinical assessment of antibiotic delivery by chitosan sponge in the high-risk diabetic foot: a case series.
Patel N; Hatch D; Wells CM; Ahn D; Harris M; Jennings JA; Haggard W; Armstrong DG
J Wound Care; 2017 Apr; 26(sup4):S32-S38. PubMed ID: 28379101
[TBL] [Abstract][Full Text] [Related]
22. Local antibiotic delivery by a bioabsorbable gel is superior to PMMA bead depot in reducing infection in an open fracture model.
Penn-Barwell JG; Murray CK; Wenke JC
J Orthop Trauma; 2014 Jun; 28(6):370-5. PubMed ID: 23948961
[TBL] [Abstract][Full Text] [Related]
23. An Effective Negative Pressure Wound Therapy-Compatible Local Antibiotic Delivery Device.
Rand BCC; Wenke JC
J Orthop Trauma; 2017 Dec; 31(12):631-635. PubMed ID: 28742785
[TBL] [Abstract][Full Text] [Related]
24. Effects of sodium acetate buffer on chitosan sponge properties and in vivo degradation in a rat intramuscular model.
Parker AC; Smith JK; Reves B; Jennings JA; Bumgardner JD; Haggard WO
J Biomed Mater Res B Appl Biomater; 2015 Feb; 103(2):387-96. PubMed ID: 24895066
[TBL] [Abstract][Full Text] [Related]
25. Chitosan-Based Film of Tyrothricin for Enhanced Antimicrobial Activity against Common Skin Pathogens Including Staphylococcus aureus.
Han SD; Sung HJ; Lee GH; Jun JH; Son M; Kang MJ
J Microbiol Biotechnol; 2016 May; 26(5):953-8. PubMed ID: 26907760
[TBL] [Abstract][Full Text] [Related]
26. Rapid degradation and non-selectivity of Dakin's solution prevents effectiveness in contaminated musculoskeletal wound models.
Mangum LC; Franklin NA; Garcia GR; Akers KS; Wenke JC
Injury; 2018 Oct; 49(10):1763-1773. PubMed ID: 30104015
[TBL] [Abstract][Full Text] [Related]
27. Tetracycline release from tripolyphosphate-chitosan cross-linked sponge: a preliminary in vitro study.
Shen EC; Wang C; Fu E; Chiang CY; Chen TT; Nieh S
J Periodontal Res; 2008 Dec; 43(6):642-8. PubMed ID: 18624950
[TBL] [Abstract][Full Text] [Related]
28. Hydrogel Dressing with a Nano-Formula against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Diabetic Foot Bacteria.
El-Naggar MY; Gohar YM; Sorour MA; Waheeb MG
J Microbiol Biotechnol; 2016 Feb; 26(2):408-20. PubMed ID: 26597531
[TBL] [Abstract][Full Text] [Related]
29. Preliminary investigation of crosslinked chitosan sponges for tailorable drug delivery and infection control.
Parker AC; Jennings JA; Bumgardner JD; Courtney HS; Lindner E; Haggard WO
J Biomed Mater Res B Appl Biomater; 2013 Jan; 101(1):110-23. PubMed ID: 22997172
[TBL] [Abstract][Full Text] [Related]
30. The Use of a Novel Antimicrobial Implant Coating In Vivo to Prevent Spinal Implant Infection.
Hegde V; Park HY; Dworsky E; Zoller SD; Xi W; Johansen DO; Loftin AH; Hamad CD; Segura T; Bernthal NM
Spine (Phila Pa 1976); 2020 Mar; 45(6):E305-E311. PubMed ID: 31593059
[TBL] [Abstract][Full Text] [Related]
31. Preliminary in vitro evaluation of an adjunctive therapy for extremity wound infection reduction: rapidly resorbing local antibiotic delivery.
Jackson SR; Richelsoph KC; Courtney HS; Wenke JC; Branstetter JG; Bumgardner JD; Haggard WO
J Orthop Res; 2009 Jul; 27(7):903-8. PubMed ID: 19105225
[TBL] [Abstract][Full Text] [Related]
32. Chitosan/montmorillonite composite nanospheres for sustained antibiotic delivery at post-implantation bone infection treatment.
Kimna C; Deger S; Tamburaci S; Tihminlioglu F
Biomed Mater; 2019 May; 14(4):044101. PubMed ID: 30991372
[TBL] [Abstract][Full Text] [Related]
33. Porous dressings of modified chitosan with poly(2-hydroxyethyl acrylate) for topical wound delivery of levofloxacin.
Siafaka PI; Zisi AP; Exindari MK; Karantas ID; Bikiaris DN
Carbohydr Polym; 2016 Jun; 143():90-9. PubMed ID: 27083347
[TBL] [Abstract][Full Text] [Related]
34. Chitosan sponges as a sustained release carrier system for the prophylaxis of orthopedic implant-associated infections.
Pawar V; Bulbake U; Khan W; Srivastava R
Int J Biol Macromol; 2019 Aug; 134():100-112. PubMed ID: 31055114
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic eluting chitosan glycerophosphate implant in the setting of acute bacterial sinusitis: a rabbit model.
Bleier BS; Kofonow JM; Hashmi N; Chennupati SK; Cohen NA
Am J Rhinol Allergy; 2010; 24(2):129-32. PubMed ID: 20338111
[TBL] [Abstract][Full Text] [Related]
36. In vitro studies of water activity and bacterial growth inhibition of sucrose-polyethylene glycol 400-hydrogen peroxide and xylose-polyethylene glycol 400-hydrogen peroxide pastes used to treat infected wounds.
Ambrose U; Middleton K; Seal D
Antimicrob Agents Chemother; 1991 Sep; 35(9):1799-803. PubMed ID: 1952851
[TBL] [Abstract][Full Text] [Related]
37. Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: an in vitro and in vivo study.
Kälicke T; Schierholz J; Schlegel U; Frangen TM; Köller M; Printzen G; Seybold D; Klöckner S; Muhr G; Arens S
J Orthop Res; 2006 Aug; 24(8):1622-40. PubMed ID: 16779814
[TBL] [Abstract][Full Text] [Related]
38. Ready-to-use injectable calcium phosphate bone cement paste as drug carrier.
Vorndran E; Geffers M; Ewald A; Lemm M; Nies B; Gbureck U
Acta Biomater; 2013 Dec; 9(12):9558-67. PubMed ID: 23954526
[TBL] [Abstract][Full Text] [Related]
39. Chitosan-polycaprolactone blend sponges for management of chronic osteomyelitis: A preliminary characterization and in vitro evaluation.
Pawar V; Srivastava R
Int J Pharm; 2019 Sep; 568():118553. PubMed ID: 31344444
[TBL] [Abstract][Full Text] [Related]
40. An off-the-shelf plasma-based material to prevent pacemaker pocket infection.
Schwartzman D; Pasculle AW; Ceceris KD; Smith JD; Weiss LE; Campbell PG
Biomaterials; 2015 Aug; 60():1-8. PubMed ID: 25965281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
